cancer biology, epigenetics
The laboratory focuses on preclinical development of novel epigenetic agents for treatment of small cell lung cancer. Areas of interest include biomarker discovery, drug combination, and mechanistic study.
The candidate should have a Ph.D.in Molecular Biology, Biochemistry or related disciplines. The successful applicant should be highly motivated, possess good communication and writing skills, and have a record of high quality publications in peer-reviewed journals.
Please send cover letter, CV and three references to Dr. Haobin Chen at firstname.lastname@example.org.
HHS, NIH, and NCI are Equal Opportunity Employers